Get started
Author

Martin Laclav

Observed names: M Laclav, M. Laclav
ORCID: 0000-0003-0523-9654
Observed ORCID: 0000-0003-0523-9654
OpenAlex ID: A5021179651
Risankizumab for Ulcerative Colitis
2024 · Edouard Louis, Stefan Schreiber, et al. · JAMA · 134
PDF
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
2024 · David T Rubin, Jessica R Allegretti, et al. · The Lancet · 113
PDF
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
2023 · Silvio Danese, Remo Panaccione, et al. · ˜The œLancet. Gastroenterology & hepatology · 75
PDF
Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma
2016 · Petr Busek, Zdislava Vanickova, et al. · Pancreatology · 40
Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss
2016 · Jan Škrha, Petr Bušek, et al. · Pancreatology · 30
Accuracy of EUS and CEH EUS for the diagnosis of pancreatic tumours
2018 · B. Bunganič, M. Laclav, et al. · Scandinavian Journal of Gastroenterology · 27
Early detection of sporadic pancreatic cancer: time for change
2017 · Přemysl Frič, Aleksi Šedo, et al. · European Journal of Gastroenterology & Hepatology · 16
Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers
2016 · Přemysl Frič, Jan Škrha, et al. · European Journal of Gastroenterology & Hepatology · 13
Precursors of pancreatic cancer
2016 · Přemysl Frič, Jan Škrha, et al. · European Journal of Gastroenterology & Hepatology · 10
Early pancreatic carcinogenesis – risk factors, early symptoms, and the impact of antidiabetic drugs
2016 · Přemysl Frič, Jan Škrha, et al. · European Journal of Gastroenterology & Hepatology · 7
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn’s disease: Results from the phase 2 GALAXI 1 trial
2026 · Anita Afzali, Silvio Danese, et al. · Inflammatory Bowel Diseases · 3
KRAS mutation assay on EUS FNA specimens from pacients with pancreatic mass
2017 · Martin Laclav · 1
[Early detection of sporadic pancreatic cancer].
2017 · Přemysl Frič, Aleksi Šedo, et al. · PubMed · 1
Spectral Pattern of Pancreatic Cancer and Metabolomic Biomarker
2017 · Bohus Bunganic, Michal Tatarkovic, et al. · Gastroenterology · 1
1034 Spectral Biomarkers of Pancreatic Cancer
2015 · Bohus Bunganic, Michal Tatarkovič, et al. · Gastroenterology · 1
Feedback is the best way to see.
2014 · B Bunganic, M Laclav, et al. · PubMed · 1
Feedback is the best way to see
2014 · B Bunganic, M Laclav, et al. · Endoscopic Ultrasound · 1
Sa1527 Prevalence of Hyperglycemia in Patients With Pancreatic Cancer
2016 · Bohus Bunganic, Martin Laclav, et al. · Gastroenterology
Su2028 KRAS Mutation Assay on EUS FNA Specimens From Pacients With Pancreatic Mass
2016 · Bohus Bunganic, Tereza Halkova, et al. · Gastroenterology
1034 Spectral Biomarkers of Pancreatic Cancer
2015 · Bohus Bunganic, Michal Tatarkovič, et al. · Gastrointestinal Endoscopy
Tu1667 Contrast Enhanced Endosonography in Pancreatic Cancer
2015 · Bohus Bunganic, Tereza Dvorakova, et al. · Gastrointestinal Endoscopy
Využití kontrastní endosonografie v diagnostice karcinomupankreatu
2014 · B. Bunganič, T. Dvořáková, et al. · Gastroenterologie a hepatologie
Contrast enhanced endosonography in diagnosis of pancreatic cancer
2014 · Bohuš Bunganič, Tereza Dvořáková, et al. · Gastroenterologie a hepatologie
Works count: 23
Citation count: 473
H-index: 9
I10-index: 9
Year
Topic
Type